Signify Health - SGFY Stock Forecast, Price & News

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Signify Health in the last year. There are currently 10 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SGFY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SGFY, but not buy additional shares or sell existing shares.
View SGFY analyst ratings or view top-rated stocks.

12 brokerages have issued 1 year price objectives for Signify Health's shares. Their SGFY share price forecasts range from $21.00 to $35.00. On average, they anticipate the company's stock price to reach $28.15 in the next year. This suggests that the stock has a possible downside of 1.7%.
View analysts price targets for SGFY or view top-rated stocks among Wall Street analysts.

Signify Health's stock was trading at $14.22 at the beginning of 2022. Since then, SGFY stock has increased by 101.3% and is now trading at $28.63.
View the best growth stocks for 2022 here.

Signify Health saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 19,340,000 shares, an increase of 25.3% from the October 31st total of 15,430,000 shares. Based on an average trading volume of 4,030,000 shares, the short-interest ratio is currently 4.8 days.
View Signify Health's Short Interest.

Signify Health, Inc. (NYSE:SGFY) released its quarterly earnings data on Tuesday, November, 9th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.03 by $0.09. The business had revenue of $199.20 million for the quarter, compared to analyst estimates of $185.04 million. Signify Health had a negative trailing twelve-month return on equity of 13.21% and a negative net margin of 66.04%.

(SGFY) raised $423 million in an IPO on Thursday, February 11th 2021. The company issued 23,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Barclays, Deutsche Bank Securities, BofA Securities, UBS Investment Bank, Baird, Piper Sandler and William Blair served as the underwriters for the IPO.

Signify Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "SGFY."

Signify Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.75%), BlackRock Inc. (1.29%), Frontier Capital Management Co. LLC (1.21%), KRYGER CAPITAL Ltd (1.18%), Beryl Capital Management LLC (0.96%) and Fred Alger Management LLC (0.95%). Insiders that own company stock include Bradford Kyle Armbrester, David Pierre, Laurel Douty, Laurence Michael Orton, Marc D Rothman and Steve Senneff.
View institutional ownership trends.

Shares of SGFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SGFY stock can currently be purchased for approximately $28.63.

Signify Health (NYSE:SGFY) has a market capitalization of $6.76 billion and generates $773.40 million in revenue each year. The company earns $19.70 million in net income (profit) each year or ($1.91) on an earnings per share basis.

The company employs 2,300 workers across the globe.

Signify Health's mailing address is 800 CONNECTICUT AVENUE, NORWALK CT, 06854. The official website for the company is www.signifyhealth.com. The company can be reached via phone at 203-541-4600 or via email at investor.relations@signifyhealth..com.